Amonafide 69408-81-7
Product Description
.cp_wz table {border-top: 1px solid #ccc;border-left:1px solid #ccc; } .cp_wz table td{border-right: 1px solid #ccc; border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;} .cp_wz table th {border-right: 1px solid #ccc;border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;}
Molecular Weight:
283.33 Amonafide produces protein-associated DNA-strand breaks through a topoisomerase II-mediated reaction, but does not produce topoisomerase I-mediated DNA cleavage. Phase 3.
Biological Activity
Through a topoisomerase II-mediated reaction, Amonafide treatment
produces DNA single-strand breaks (SSB), double-strand breaks (DSB), and
DNA-protein cross-links in human myeloid leukemia cells. Amonafide
treatment inhibits conlony formation of the leukemic cell lines and the
normal human bone marrow GM-CFC in a dose-dependent manner.
Amonafide
does not produce topoisomerase I-mediated DNA cleavage even at 100 μM.
The m-AMSA-resistant line is less than 2-fold resistant to Amonafide Amonafide interferes with the DNA breakage-reunion activity of
mammalian DNA topoisomerase II resulting in DNA cleavage stimulation.
Compared with those of other antitumor drugs, Amonafide-stimulated
cleavage intensity patterns are markedly different. Amonafide highly
prefers a cytosine, and excludes guanines and thymines instead, at
position -1, with lower preference for an adenine at position +1. Topoisomerase II-mediated DNA cleavage induced by Amonafide is affected
only slightly (less than 3-fold) by 1 mM ATP, suggeting that Amonafide
is an ATP-insensitive topoisomerase II inhibitor in contrast to
doxorubicin, etoposide, and mitoxantrone.
Amonafide
significantly inhibits the growth of HT-29, HeLa, and PC3 cells with
IC50 of 4.67 μM, 2.73 μM, and 6.38 μM, respectively. Amonafide is unaffected by P-glycoprotein-mediated efflux, unlike those
of the classical topoisomerase II Inhibitors (daunorubicin, doxorubicin,
idarubicin, etoposide, and mitoxantrone).
Contact us if you need more details on 69408-81-7. We are ready to answer your questions on packaging, logistics, certification or any Other aspects about Amonafide 69408-81-7、69408-81-7 Amonafide. If these products fail to match your need, please contact us and we would like to provide relevant information.
Molecular Weight:
283.33 Amonafide produces protein-associated DNA-strand breaks through a topoisomerase II-mediated reaction, but does not produce topoisomerase I-mediated DNA cleavage. Phase 3.
Biological Activity
Through a topoisomerase II-mediated reaction, Amonafide treatment
produces DNA single-strand breaks (SSB), double-strand breaks (DSB), and
DNA-protein cross-links in human myeloid leukemia cells. Amonafide
treatment inhibits conlony formation of the leukemic cell lines and the
normal human bone marrow GM-CFC in a dose-dependent manner.
Amonafide
does not produce topoisomerase I-mediated DNA cleavage even at 100 μM.
The m-AMSA-resistant line is less than 2-fold resistant to Amonafide Amonafide interferes with the DNA breakage-reunion activity of
mammalian DNA topoisomerase II resulting in DNA cleavage stimulation.
Compared with those of other antitumor drugs, Amonafide-stimulated
cleavage intensity patterns are markedly different. Amonafide highly
prefers a cytosine, and excludes guanines and thymines instead, at
position -1, with lower preference for an adenine at position +1. Topoisomerase II-mediated DNA cleavage induced by Amonafide is affected
only slightly (less than 3-fold) by 1 mM ATP, suggeting that Amonafide
is an ATP-insensitive topoisomerase II inhibitor in contrast to
doxorubicin, etoposide, and mitoxantrone.
Amonafide
significantly inhibits the growth of HT-29, HeLa, and PC3 cells with
IC50 of 4.67 μM, 2.73 μM, and 6.38 μM, respectively. Amonafide is unaffected by P-glycoprotein-mediated efflux, unlike those
of the classical topoisomerase II Inhibitors (daunorubicin, doxorubicin,
idarubicin, etoposide, and mitoxantrone).
Contact us if you need more details on 69408-81-7. We are ready to answer your questions on packaging, logistics, certification or any Other aspects about Amonafide 69408-81-7、69408-81-7 Amonafide. If these products fail to match your need, please contact us and we would like to provide relevant information.
Product Categories : DNA Damage > Topoisomerase Inhibitor
Other Products
Hot Products
Astragaloside AChlortetracycline HCl 64-72-2Paclitaxel 33069-62-4Dexamethasone Acetate 1177-87-3Dinaciclib (SCH727965) 779353-01-4CHIR-124 405168-58-3Ro3280 1062243-51-9TAME 901-47-3CCG-1423 285986-88-110058-F4 403811-55-2Dabigatran (BIBR 953) 211914-51-1H 89 2HCl 130964-39-5T0901317 293754-55-9Aprepitant 170729-80-3Turofexorate Isopropyl (XL335) 629664-81-9BMS-378806 357263-13-9